Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus.
A recombinant adenovirus was constructed by inserting the human immunodeficiency virus type 1 (HIV-1) envelope gene downstream from the early region 3 (E3) promoter of adenovirus type 5 (Ad5), replacing the coding sequences of E3. The recombinant virus replicated as efficiently as the parent virus in all cell lines tested. Human cells infected with the recombinant virus synthesized the HIV-1 envelope precursor gp160, which was efficiently processed to the envelope glycoproteins gp120 and gp41. A human T-lymphoblast line (Molt-4) infected with the recombinant virus expressed HIV-1 envelope glycoproteins on the cell surface, leading to syncytium formation. The envelope gene was expressed from the E3 promoter at early times after infection and at late times from the major late promoter. When cotton rats were infected with the recombinant virus, antibodies against the HIV-1 envelope glycoproteins could be expressed in an immunoreactive form by the recombinant adenovirus, further illustrating the usefulness of adenoviruses as expression vectors.
Dewar
R L
RL
Division of Molecular Virology and Immunology, Georgetown University School of Medicine, Washington, D.C. 20007.
Natarajan
V
V
Vasudevachari
M B
MB
Salzman
N P
NP
D000260:Adenoviruses, Human / Q000235:genetics; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D003411:Arvicolinae; D002460:Cell Line; D004274:DNA, Recombinant; D005786:Gene Expression Regulation; D015488:HIV Antigens / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism; D015699:HIV Envelope Protein gp120; D019302:HIV Envelope Protein gp160; D015700:HIV Envelope Protein gp41; D015497:HIV-1 / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D007700:Kinetics; D010957:Plasmids; D011498:Protein Precursors / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism; D012191:Retroviridae Proteins / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism; D014162:Transfection; D014759:Viral Envelope Proteins / Q000096:biosynthesis* / Q000276:immunology / Q000378:metabolism
D000914:Antibodies, Viral; D004274:DNA, Recombinant; D015488:HIV Antigens; D015699:HIV Envelope Protein gp120; D019302:HIV Envelope Protein gp160; D015700:HIV Envelope Protein gp41; D011498:Protein Precursors; D012191:Retroviridae Proteins; D014759:Viral Envelope Proteins